Back
XTL Biopharmaceuticals Stock Price Chart
FREE REPORT: 2025 Gold Price Outlook
Get Your Copy of "2025 Gold Forecast: A Perfect Storm for Demand" Here.
Sell
45
XTLB
XTL Biopharmaceuticals
Last Price:
$2.05
Seasonality Move:
19.96%
7 Day Trial
ALL ACCESS PASS
$
7
2025 Gold Forecast: A Perfect Storm for Demand
Discover our Gold Price Outlook for 2025--FREE--here-
The current trend is relatively stagnant and XTLB is experiencing buying pressure, which is a positive indicator for future bullish movement.
XTL Biopharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.63 | Buy |
| 20-day SMA: | 1.76 | Buy |
| 50-day SMA: | 1.82 | Buy |
| 200-day SMA: | 2.33 | Sell |
| 8-day EMA: | 1.68 | Buy |
| 20-day EMA: | 1.73 | Buy |
| 50-day EMA: | 1.88 | Buy |
| 200-day EMA: | 2.03 | Sell |
XTL Biopharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.06 | Sell |
| Relative Strength Index (14 RSI): | 55.25 | Buy |
| Chaikin Money Flow: | 1090 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.63 - 1.93) | Buy |
| Bollinger Bands (100): | (1.78 - 2.6) | Sell |
XTL Biopharmaceuticals Technical Analysis
| Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for XTL Biopharmaceuticals Stock
Is XTL Biopharmaceuticals Stock a Buy?
-
XTL Biopharmaceuticals share price is 1.88 while XTLB 8-day simple moving average is 1.63, which is a Buy signal.
-
The stock price of XTLB is 1.88 while XTL Biopharmaceuticals 20-day SMA is 1.76, which makes it a Buy.
-
XTL Biopharmaceuticals 50-day simple moving average is 1.82 while XTLB share price is 1.88, making it a Buy technically.
-
XTLB stock price is 1.88 and XTL Biopharmaceuticals 200-day simple moving average is 2.33, creating a Sell signal.
XTLB Technical Analysis vs Fundamental Analysis
Sell
45
XTL Biopharmaceuticals (XTLB)
is a Sell
Is XTL Biopharmaceuticals a Buy or a Sell?
-
XTL Biopharmaceuticals stock is rated a SellThe current XTL Biopharmaceuticals [XTLB] share price is $1.88. The Score for XTLB is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
XTL Biopharmaceuticals Stock Info
Market Cap:
10.2M
Price in USD:
1.88
Share Volume:
1.1K
XTL Biopharmaceuticals 52-Week Range
52-Week High:
4.99
52-Week Low:
0.77
Sell
45
XTL Biopharmaceuticals (XTLB)
is a Sell
XTL Biopharmaceuticals Share Price Forecast
-
What is the XTL Biopharmaceuticals stock price today?The XTL Biopharmaceuticals stock price is 1.88 USD today.
-
Will XTLB stock go up or go down?XTL Biopharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is XTL Biopharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, XTL Biopharmaceuticals is overvalued.
Is XTL Biopharmaceuticals Stock a Buy?
-
XTL Biopharmaceuticals share price is 1.88 while XTLB 8-day exponential moving average is 1.68, which is a Buy signal.
-
The stock price of XTLB is 1.88 while XTL Biopharmaceuticals 20-day EMA is 1.73, which makes it a Buy.
-
XTL Biopharmaceuticals 50-day exponential moving average is 1.88 while XTLB share price is 1.88, making it a Buy technically.
-
XTLB stock price is 1.88 and XTL Biopharmaceuticals 200-day simple moving average is 2.03, creating a Sell signal.
Technical Analysis of XTL Biopharmaceuticals
Should I short XTL Biopharmaceuticals stock?
-
XTLB Moving Average Covergence Divergence (MACD) indicator is -0.06, suggesting XTL Biopharmaceuticals is a Sell
-
XTL Biopharmaceuticals Relative Strength Index (RSI) is 55.25, which suggest XTL Biopharmaceuticals is overbought
-
The Bollinger Bands (25) for XTL Biopharmaceuticals is (1.63 - 1.93), which suggest XTL Biopharmaceuticals is a Sell
-
The Bollinger Bands (100) for XTL Biopharmaceuticals is (1.78 - 2.6), which suggest XTL Biopharmaceuticals is a Sell
* XTL Biopharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.